This website uses cookies

Read our Privacy policy and Terms of use for more information.

In partnership with

Per-share pricing is one of the least informative numbers in finance. It is market value divided by share count, so a $4 stock and a $400 stock tell you nothing about which company is larger, healthier, or growing faster.

A name trades in the single digits because of how many shares it issued, not how good the business underneath it is, and the market knows it: a low nominal price is a quirk of share structure, but occasionally there’s a gap when paired with a story the market quit on too early or passed over.

That gap is the reason to screen down in the sub-$10 trenches. The megacaps everyone already owns trade for hundreds of dollars a share and get combed over by every analyst on the Street, so the mispricings are thin.

In the single digits, a company can post a record quarter, sign a content-licensing deal with OpenAI, or bring a second uranium mine into production and still change hands for less than the price of lunch, because the float is large, or the turnaround is early, or the sector spent the last cycle out of favor.

Seven of them follow, across defense drones, connected-TV advertising, uranium, crude tankers, online retail, pediatric health, and the strangest turn yet in the AI-content wars. We’ll start with the smallest and most aggressive of the bunch.

The Connected-TV Compounder: Nexxen $NEXN ( ▲ 2.0% )

Nexxen is the rare name in this group that is already profitable, and the rare AdTech small-cap that has turned the connected-TV shift into actual earnings rather than a slide-deck promise.

The $482M company, formerly Tremor International (renamed in 2024), runs a full advertising stack of a demand-side platform, a supply-side platform, and a data platform, with its real edge sitting in the data layer: proprietary automatic-content-recognition data from smart-TV partners that lets advertisers target and measure CTV campaigns other independents can't match.

The catalyst is momentum that is showing up in the numbers. Nexxen reported record first-quarter 2026 results and lifted its full-year outlook, with management leaning into a newly launched AI-native DSP interface and a string of CTV inventory deals, home-screen placements with TV makers and an in-app video partnership with Unity among them.

There's even a clean macro kicker: 2026 is a U.S. midterm year, and Nexxen has rolled out a product aimed specifically at programmatic political campaigns, a category that floods CTV with spend every even-numbered cycle. Analysts covering the name carry buy ratings and price targets around $11, implying ~30% upside from current per-share pricing.

The risk is the company it keeps. Independent AdTech lives downstream of Google, Amazon, and Meta, which control the bulk of digital ad budgets and can reprice the open market at will; a single large buyer shifting spend can dent a quarter, as peers have learned the hard way.

Nexxen's data moat and CTV exposure are the differentiators that are supposed to insulate it, and so far they have. At a high-single-digit share price and a market cap under half a billion, you are paying a modest multiple (7x forward earnings) for a profitable, growing platform in the one corner of advertising that is still taking share, with the standing caveat that the giants are never far away.

A Small-Cap Uranium Stock Under $10: Ur-Energy $URG ( ▲ 3.85% )

Ur-Energy is a working uranium producer trading like a developer, and its catalyst this year is the simplest kind: a second mine coming online.

The $520M Wyoming company has commenced mining at its Shirley Basin in-situ recovery project, its second production source alongside the flagship Lost Creek operation, with uranium-loaded resin set to move to Lost Creek for processing over the summer.

Shirley Basin is licensed for up to 2.0 million pounds of U3O8 a year against a roughly nine-year mine life, and bringing it up materially expands Ur-Energy's domestic output at exactly the moment U.S. utilities are scrambling for non-Russian supply.

The pricing backdrop is doing the heavy lifting. Ur-Energy's first-quarter 2026 sales went out at an average of $70.98 a pound, well above where the company was selling a year earlier amid a global rise in demand for nuclear energy expansion (both on its own merits and in reaction to oil shocks) while cash costs fell to $37.51 a pound, and the company closed the quarter with about $122.8 million in cash to fund the Shirley Basin ramp without leaning hard on the market. Uranium term prices sitting at multi-year highs, the nuclear restart wave, and data-center power demand are the macro forces behind the contract book.

The caveat is that the quarter itself was small. Most of Ur-Energy's 2026 deliveries are weighted to the back half of the year, so near-term revenue looks thin against the production story, and the stock has historically funded its build-out through at-the-market equity and convertible notes; dilution is a recurring feature, not a one-time event. Uranium equities are also violently cyclical and trade on the spot price as much as on company execution.

But among single-digit uranium names, Ur-Energy is one of the few already mining, selling into strong realized prices, and adding a second source rather than promising one.

The Free Newsletter Fintech and Finance Execs Actually Read

f you work in fintech or finance, you already have too many tabs open and not enough time.

Fintech Takes is the free newsletter senior leaders actually read. Each week, I break down the trends, deals, and regulatory moves shaping the industry — and explain why they matter — in plain English.

No filler, no PR spin, and no “insights” you already saw on LinkedIn eight times this week. Just clear analysis and the occasional bad joke to make it go down easier.

Get context you can actually use. Subscribe free and see what’s coming before everyone else.

The Cyclical Income Play: Nordic American Tankers $NAT ( ▼ 6.55% )

Nordic American Tankers is the income name here, with the asterisk that the income moves with the freight market. The $1.24B Bermuda-based company owns a homogeneous fleet of roughly 20 Suezmax crude tankers and pays a variable quarterly dividend tied directly to cash flow, which means the payout swells when rates are strong and shrinks when they aren't.

Right now they are strong.

Management called first-quarter 2026 the best Suezmax market in decades, posting net income of $46.3 million and average daily rates of $47,600 per ship, and declared a $0.22 per-share dividend for the quarter, its 115th consecutive payout.

The forward setup is the interesting part. Nordic American has booked roughly 90% of its second-quarter fleet days at around $68,000 per day, well above first-quarter levels, with voyages already extending into the third quarter, a rare bit of visibility in a notoriously opaque business, helped along by Middle East disruption and a Suezmax orderbook too thin to replace an aging fleet. The chairman has been buying stock in the open market alongside shareholders.

Note, of course, that the “best market in decades” is itself the risk; tanker earnings are mean-reverting, and buying near a cyclical peak is how income investors get hurt, particularly with free cash flow that turns negative when rates roll over. NAT is a clean way to own the current tanker up-cycle and collect cash while it lasts, but don’t make it a buy-and-forget yield bet.

Top Small-Cap Drone Stock Under $10: AgEagle Aerial Systems $UAVS ( ▲ 5.76% )

AgEagle Aerial Systems, now operating as EagleNXT, spent 2026 remaking a long-struggling commercial-drone business into a defense supplier, and the order flow is starting to show it.

The $53M maker's eBee VISION fixed-wing ISR drone was selected by the U.S. Army for training use, drew follow-on orders tied to the Army's 7th Army Training Command, and earned a listing on the Army's online procurement marketplace, the kind of administrative milestone that turns a one-off sale into a repeatable channel.

It also opened a domestic manufacturing center in Allen, Texas, positioning its hardware as NDAA-compliant, a meaningful distinction in a market actively purging Chinese-made drones from federal and commercial fleets, and formed a counter-drone joint venture, ThirdEye USA, to push beyond airframes into detection.

The backdrop helps: drone reshoring and counter-UAS spending are among the few defense line items with bipartisan momentum and a regulatory push behind them. AgEagle's positioning against that is the bull case.

The caution is the balance sheet and the share price. At roughly sub-$1 a share and ~$50M market cap, UAVS is in deep micro-cap territory, with a stock that swings far harder than the market (a whopping 2.7x beta!) and a long history of dilution that has repeatedly funded operations at shareholders' expense.

Revenue is still measured in single-digit millions per quarter, and the gap between “selected for training” and “scaled program of record” is wide and slow to close.

This is the speculative end of the range: a defense pivot attached to a fragile cap structure, where the contracts are early and the company has to keep executing, and keep its share count under control, to turn them into a viable, continued-success business model.

The Turnaround That's Actually Turning: Stitch Fix $SFIX ( ▲ 5.58% )

Stitch Fix spent years as a cautionary tale, a pandemic darling that fell from nearly $100 to the low single digits as growth evaporated (during ZIRP mania, to be fair), which is exactly why the current setup is interesting: the turnaround is no longer hypothetical.

The $605M online personal-styling company reported fiscal third-quarter results in June that beat on every line and sent the stock up about 15% in a session, marking its fifth consecutive quarter of revenue growth.

Management raised full-year guidance to roughly $1.35 billion in revenue and $49 to $52 million in adjusted EBITDA, and is buying back stock, all of it on a balance sheet with no debt and around $240 million in cash.

What changed is the model. Stitch Fix has leaned harder into the thing that always differentiated it, pairing human stylists with recommendation algorithms, while cutting the marketing bloat that torched cash during the growth years.

Revenue per active client is at record levels even as the total client count has stopped falling, which is the order in which a subscription-style retailer is supposed to recover: stabilize the base, then grow it.

The caution is that this is still a slow-growth story dressed as a turnaround. Revenue is expanding in the low single digits, not snapping back, and active clients remain below where they were a year ago; the durability of the recovery depends on re-accelerating customer acquisition without re-inflating the marketing spend that nearly sank the model.

Apparel retail is also fiercely competitive and discretionary, exposed to any consumer pullback. But Stitch Fix has done the hard part. It is profitable on an adjusted basis, growing again, and returning cash, and at a sub-$5 share price the market is still pricing it closer to the cautionary tale than to the operating reality.

A Small-Cap Health Stock Under $10: Owlet $OWLT ( ▲ 2.81% )

Owlet is the most contrarian inclusion here, and the one where the catalyst is a strategy shift rather than a soaring chart; the stock is down sharply on the year. The $160M company makes smart infant-monitoring hardware, the Dream Sock and its newer Dream Sight and Dream Duo lines, and is trying to convert a one-time-hardware business into a recurring pediatric-health platform.

Subscription revenue hit a quarterly record, gross margin expanded to 54.5%, and management raised its full-year adjusted-EBITDA guidance to $7 to $9 million, a 250% to 350% jump over 2025, signaling a deliberate turn toward profitable growth over top-line at any cost. Co-founder Kurt Workman has retaken the CEO role to drive that transition.

The reason the stock sits where it does is that the same quarter cut the other way on revenue: first-quarter 2026 sales grew just 6.4% to $22.5 million, adjusted EBITDA was negative $1.5 million, and the company actually lowered its full-year revenue outlook to $118 to $122 million while raising the profitability target, a trade the market punished, with analysts trimming price targets even while keeping buy ratings.

Hardware sales are softening, a major retail partner has been right-sizing inventory, and tariffs on Asian-made devices are a live cost headwind. A securities offering on file adds the usual dilution overhang.

So the bull case is narrow and specific: a beaten-down small-cap deliberately trading revenue growth for margin and subscription mix, betting that a connected-health platform is worth more than a hardware vendor.

If the subscription flywheel and the EBITDA ramp hold, the current valuation looks like pessimism. If hardware keeps slipping and the platform doesn't scale, it's a value trap. It is the highest-variance name here, the one most dependent on management delivering the pivot it is promising.

The Contrarian AI Trade: Getty Images $GETY ( ▼ 5.73% )

Getty Images is the catalyst story that closes this list, and it is a strange one: the company spent years cast as roadkill for generative AI, and just turned the same technology into a revenue channel.

Earlier this week, Getty announced a multi-year display agreement with OpenAI to surface its licensed visual content inside ChatGPT's search and discovery experiences, and the stock, which had touched an all-time low near $0.58 days earlier, roughly doubled on the news.

The reframe is the whole thesis: a company sued Stability AI to defend its library, then signed a deal that monetizes that same rights-cleared library as infrastructure for the AI platforms that once threatened it. A parallel arrangement with Perplexity points in the same direction.

There are two large complications, and both have to sit in the room with the bull case. The first is corporate structure: Getty is in the middle of a proposed merger of equals with Shutterstock. The DOJ cleared it without conditions, but the UK competition regulator has required Shutterstock to divest its global editorial business before the deal can proceed, leaving the combination contingent and unresolved, with a long-stop date in October 2026. Anyone buying GETY today is buying into a pending merger as much as a content business.

The second is the balance sheet: Getty carries roughly $2 billion in debt, runs unprofitable, posted barely-positive revenue growth in its latest quarter, and spent months trading below $1, which raises live NYSE listing-compliance questions. Insiders have been net sellers, not buyers.

So the OpenAI deal is best read as optionality, not a number: no financial terms were disclosed, and a display licensing arrangement is a long way from transforming a leveraged, low-growth content company.

But the strategic logic holds, the library is scarce, and at a roughly $500M market cap the market is barely pricing the AI-licensing angle at all. A leveraged, unprofitable content company in a contingent merger, sitting on the one asset the AI platforms now want to license.

Hit reply with thoughts, corrections, or names worth a closer look. If you’re seeing this outside of your inbox, shoot me an email here.

Keep digging and see you next time!

Disclosure: Long UAVS

Reply

Avatar

or to participate

Keep Reading